name:-0.016989946365356
name:-0.010922908782959
name:-0.0082061290740967
BioPharmX, Inc. Patent Filings

BioPharmX, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BioPharmX, Inc..The latest application filed is for "ebastine topical composition".

Company Profile
12.16.21
  • BioPharmX, Inc. - San Jose CA US
  • BioPharmX, Inc. - Menlo Park CA US
  • BioPharmX, Inc - Menlo Park CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Pharmaceutical tetracycline composition for dermatological use
Grant 10,881,672 - Chen , et al. January 5, 2
2021-01-05
Ebastine Topical Composition
App 20200129495 - CHEN; Xin ;   et al.
2020-04-30
Pharmaceutical Tetracycline Composition For Dermatological Use
App 20200046739 - Chen; Xin ;   et al.
2020-02-13
Magnesium Chloride Composition For Dermatological Use
App 20190328775 - CHAN; Kin F.
2019-10-31
Magnesium chloride composition for dermatological use
Grant 10391121 -
2019-08-27
Pharmaceutical tetracycline composition for dermatological use
Grant 10,391,108 - Chen , et al. A
2019-08-27
Topical Compositions With Stable Solubilized Selective Retinoids And/or Tetracycline-class Antibiotics
App 20190255078 - CHEN; Xin ;   et al.
2019-08-22
Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
Grant 10,159,686 - Yamamoto Dec
2018-12-25
Magnesium Chloride Composition For Dermatological Use
App 20180318342 - CHAN; Kin F.
2018-11-08
Solid Oral Dosage Form For Breast Symptoms
App 20180296594 - Kessler; Jack ;   et al.
2018-10-18
Solid oral dosage form for breast symptoms
Grant 10,034,899 - Kessler , et al. July 31, 2
2018-07-31
Pharmaceutical Tetracycline Composition For Dermatological Use
App 20180185394 - Chen; Xin ;   et al.
2018-07-05
Dosage Form Comprising An Active Ingredient And A Plurality Of Solid Porous Microcarriers
App 20180177806 - Yamamoto; Akira
2018-06-28
Pharmaceutical tetracycline composition for dermatological use
Grant 9,918,998 - Chen , et al. March 20, 2
2018-03-20
Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
Grant 9,901,586 - Yamamoto February 27, 2
2018-02-27
Oral Iodine Dosage Form
App 20170304359 - Elliott; Russell P. ;   et al.
2017-10-26
Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
Grant 9,642,867 - Yamamoto May 9, 2
2017-05-09
Dosage Form Comprising An Active Ingredient And A Plurality Of Solid Porous Microcarriers
App 20170007628 - Yamamoto; Akira
2017-01-12
Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
Grant 9,474,720 - Yamamoto October 25, 2
2016-10-25
Novel Encapsulation Of Fluorescent, Photo-sensitive, Or Oxygen-sensitive Active Ingredient For Topical Application
App 20160287615 - Chan; Kin F. ;   et al.
2016-10-06
Pharmaceutical Tetracycline Composition For Dermatological Use
App 20160279152 - Chen; Xin ;   et al.
2016-09-29
Dosage Form Comprising An Active Ingredient And A Plurality Of Solid Porous Microcarriers
App 20150209296 - Yamamoto; Akira
2015-07-30
Solid Oral Dosage Form For Breast Symptoms
App 20150147400 - Kessler; Jack ;   et al.
2015-05-28
Dosage Form Comprising An Active Ingredient And A Plurality Of Solid Porous Microcarriers
App 20150125496 - Yamamoto; Akira
2015-05-07
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed